The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

An analysis of pooled data from two large finerenone trials identified key risk factors for hyperkalemia in patients with CKD ...

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The New Commonwealth Fund, born out of a sense of urgency to end systemic racism in 2020, is now weighing how to stay ...

Vertex Pharmaceuticals has caught investors’ eyes, but its stock performance isn’t exactly a mic-drop moment. Despite massive ...

San Jose, USA-based biotech Allay Therapeutics today announced the completion of a $57.5 million Series D financing round ...

Duchenne muscular dystrophy (DMD) has long been one of the most devastating genetic disorders to affect children. Marked by progressive muscle degeneration, early loss of mobility, and eventual ...

Botanix launches a decentralized Bitcoin sidechain with a 16-node federation, using the Spiderchain protocol for ...

AARP, Con Edison, Delta, Habitat for Humanity, and moreNEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Newsweek, in partnership with Plant-A Insights Group, is proud to announce the results of the America ...